MARKET DEFINITION

Although pharmaceutical corporations have made significant investments in direct-to-consumer marketing, prescribers are the ones who create revenue. Commercials alone won't persuade doctors and other medical professionals with prescription privileges. Before they will write their patients a prescription for the medication, they first need a live person to clarify their concerns and increase their faith in it. Pharma businesses may be able to hire a high-performing sales force through sales outsourcing at a set price. Contract sales outsourcing also engages in non-personal promotion, which is becoming a highly successful method of persuading doctors. Giving doctors information electronically is part of the non-personal promotion.

MARKET DYNAMICS

The pharmaceutical contract sales outsourcing (CSO) market will be driven by a specific organization's focused concentration on sales. The pharmaceutical industry may easily concentrate on R&D thanks to this. Outsourcing the sales comes to the rescue since the costs connected with the size of the sales team the pharmaceutical business requires to considerably increase national coverage and raise awareness of its drug are high. The industry is also driven by the growing popularity of smartphones since during their leisure time, doctors can review the pertinent information that has been shared with them on social media. This aids in increasing clinicians' knowledge of the individual health problem's technical complexities.

REPORT SCOPE  

The report titled “Global Pharmaceutical Contract Sales Outsourcing (CSO) Market – Size, Share, Growth, Opportunities, and Competitive Analysis, 2022 – 2028” offers strategic visions into the global Pharmaceutical Contract Sales Outsourcing (CSO) market along with the market size (Value in “US$ Mn”) for the historical period 2017 to 2021 and estimates for the forecast period 2022 to 2028. The RI report is an in-depth study of the global Pharmaceutical Contract Sales Outsourcing (CSO) market with a strong focus on key market trends, vital player strategies, and market forecasts. The study also covers key market dynamics, including drivers, restraints, opportunities, challenges, and existing and upcoming pathways that help CXOs make critical business decisions effectively. The global Pharmaceutical Contract Sales Outsourcing (CSO) Market is predicted to grow at a significant CAGR over the forecast period from 2022 to 2028.

GEOGRAPHICAL OVERVIEW  

The research report includes a detailed overview of the industry comprising quantitative and qualitative information. It gives a broad overview of the worldwide market forecasts for major segments. It also includes market size and forecast projections for five key regions: North America, Europe, Asia-Pacific (APAC), South America, and the Middle East & Africa (MEA), for the years 2017 to 2028. The market is further divided by categories and countries within each province. The research scrutinizes and forecasts over 20 nations worldwide, as well as the present trend and possibilities in these regions.

MARKET SEGMENTATION

The Global Pharmaceutical Contract Sales Outsourcing (CSO) Market is segmented based on Service, Therapeutic Area, and region. Based on Service, the market has been segmented into Personal Promotion, Non-personal Promotion, and Others, whereas based on Therapeutic Area, the market comprises Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others.

COMPETITION LANDSCAPE

The RI research report discusses noteworthy developments in the industry as well as organic and inorganic growth strategies being adopted by the Pharmaceutical Contract Sales Outsourcing (CSO) market players. The report covers industry activities, including new product launches, mergers & acquisitions, business partnerships, and various expansion initiatives being undertaken by the active players in the market. These developments pave the path for various market participants to strengthen their positioning as well as expand their consumer base. The positive market outlook for the global Pharmaceutical Contract Sales Outsourcing (CSO) market is anticipated to present lucrative growth opportunities to the market players. The report also offers detailed profiles of major players in the global Pharmaceutical Contract Sales Outsourcing (CSO) market, emphasizing the strategic initiatives, financial information, SWOT analysis, and key development in the Pharmaceutical Contract Sales Outsourcing (CSO) industry in the past three years.

Key players in the Global Pharmaceutical Contract Sales Outsourcing (CSO) Market have adopted various organic as well as inorganic growth strategies to strengthen their market positioning. Prominent players in the market include:

• Ashfield (UDG Healthcare plc)
• inVentiv Health, Inc. (Syneos Health)
• IQVIA
• Granard Pharmaceutical Sales & Marketing
• Vanguard Pharma, Inc.
• GTS Solution
• EVERSANA
• MaBiCo
• QFR Solutions
• Pharmaforce Ireland Ltd.
• Sales Focus, Inc.
• Amplity Health
• PharmaLex GmbH

COVID-19 IMPACT ANALYSIS ON GLOBAL PHARMACEUTICAL CONTRACT SALES OUTSOURCING (CSO) MARKET  

The COVID-19 pandemic is still a very personal, individual experience that is also a once-in-a-lifetime worldwide phenomenon with far-reaching consequences. The epidemic has wreaked havoc on people's lives in all nations and communities and also had a negative impact on global economic development in 2020, unlike anything seen in almost a century. The pandemic severely impacted key economies such as India, Brazil, the U.S., France, Russia, the UK, Italy, Turkey, and Argentina. According to estimates, the virus slowed global economic growth by -3.4 percent to -7.6 percent in 2020, with a rebound of 4.2 percent to 5.6 percent expected in 2021. In 2020, global commerce was expected to decline by 5.3 percent, but it is expected to rise by 8.0 percent in 2021.

In contrast to the global economic downturn in the first half of 2020, the economy began to showcase symptoms of a two-track recovery post the second quarter of 2020, with a fledgling rebound in developed nations, however, slower growth in emerging economies. The outbreak of the Covid-19 pandemic has not only resulted in halted production activity but has also disrupted the global supply chain. The research goes on to evaluate the current and future implications of the COVID-19 pandemic both on the target as well as broader market, thereby, providing accurate and trustworthy forecasts.

RESEARCH PROGRAM DESIGN

KEY QUESTIONS ANSWERED

1. What is the current size of the global Pharmaceutical Contract Sales Outsourcing (CSO) market?
2. What will be the growth rate of the market over the forecast period?
3. Who are the key manufacturers/vendors in the Pharmaceutical Contract Sales Outsourcing (CSO) market space?
4. What are the major market opportunities and market risks faced by the market?
5. What is the impact of COVID-19 on the market?
6. What are the revenue, sales, and price analysis of the top manufacturers in this market?
7. What are the key outcomes of Porter's five forces model?
8. Who are the distributors, traders, and vendors in the industry?

REASONS FOR BUYING THIS REPORT:  

• The report offers comprehensive data on the Pharmaceutical Contract Sales Outsourcing (CSO) market elaborating on the current state and future growth prospects both globally and regionally
• It offers a six-year market forecast trend evaluating the impact of drivers and restraints and supporting factors for growth
• The report offers deep-dive insights into each market segment and critical factors responsible for its growth
• The report presents precise picture of the dynamic competitive landscape which helps our client advance their market position
• The comprehensive analysis of the market along with the inclusion of analyst recommendations ensures that our clients make informed business decisions
• Cross-segment country-level analysis included in the report which provides granular analysis of more than 20+ countries covered in the report scope
• The study includes detailed profiles of major manufacturers to help our readers gain holistic overview of the market competitors and consequently align their business strategies

Chapter 1. Executive Summary
1.1. Market Outlook
1.2. Market Segment Outlook
1.3. Geography Outlook
1.4. Absolute $ Opportunity

Chapter 2. Research Methodology
2.1. Research Approach
2.2. Scope, Definition, and Assumptions
2.3. Data Sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary Data Mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective

Chapter 3. Market Outlook
3.1. Introduction
3.2. Key Trends
3.2.1. Service Trends
3.2.2. Therapeutic Area Trends
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Impact Analysis of Market Drivers
3.3.2. Market Restraints
3.3.2.1. Impact Analysis of Market Restraints
3.3.3. Market Opportunities
3.3.3.1. Impact Analysis of Market Opportunities
3.3.4. Market Challenges
3.3.4.1. Impact Analysis of Market Challenges
3.4. Porter’s Five Forces’ Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of New Entrant
3.4.4. Threat of Substitutes
3.4.5. Competitive Rivalry
3.5. Value Chain Analysis: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market
3.6. COVID-19 Impact Assessment in Pharmaceutical Contract Sales Outsourcing (CSO) Market
3.6.1. Impact Assessment on Global Pharmaceutical Contract Sales Outsourcing (CSO) Market
3.6.2. Market Trends and Opportunities in the Covid-19 Landscape

Chapter 4. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
4.1. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Share, By Service, 2017 - 2028 (USD Million)
4.1.1. Personal Promotion
4.1.2. Non-personal Promotion
4.1.3. Others

Chapter 5. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)
5.1. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Share, By Therapeutic Area, 2017 - 2028 (USD Million)
5.1.1. Cardiovascular Disorders
5.1.2. Oncology
5.1.3. Metabolic Disorders
5.1.4. Neurology
5.1.5. Orthopedic Diseases
5.1.6. Infectious Diseases
5.1.7. Others

Chapter 6. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Geography, 2017 - 2028 (USD Million)
6.1. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Share, By Geography, 2017 - 2028 (USD Million)
6.1.1. Market Therapeutic Area and Projections, by Countries, 2017 - 2028 (USD Million)
6.1.2. Market Share and CAGR Comparison, by Countries, 2021 (%)

Chapter 7. North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Countries, 2017 - 2028 (USD Million)
7.1. North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
7.1.1. Market Therapeutic Area and projections, 2017 - 2028 (USD Million)
7.1.2. North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
7.1.3. North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)
7.2. North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Countries, 2017 - 2028 (USD Million)
7.2.1. U.S. Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
7.2.1.1. U.S. Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
7.2.1.2. U.S. Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)
7.2.2. Canada Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
7.2.2.1. Canada Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
7.2.2.2. Canada Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)
7.2.3. Mexico Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
7.2.3.1. Mexico Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
7.2.3.2. Mexico Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

Chapter 8. Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Countries, 2017 - 2028 (USD Million)
8.1. Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
8.1.1. Market Therapeutic Area and projections, 2017 - 2028 (USD Million)
8.1.2. Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
8.1.3. Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)
8.2. Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Countries, 2017 - 2028 (USD Million)
8.2.1. Germany Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
8.2.1.1. Germany Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
8.2.1.2. Germany Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)
8.2.2. France Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
8.2.2.1. France Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
8.2.2.2. France Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)
8.2.3. UK Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
8.2.3.1. UK Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
8.2.3.2. UK Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)
8.2.4. Italy Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
8.2.4.1. Italy Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
8.2.4.2. Italy Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)
8.2.5. Spain Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
8.2.5.1. Spain Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
8.2.5.2. Spain Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)
8.2.6. NORDIC Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
8.2.6.1. NORDIC Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
8.2.6.2. NORDIC Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)
8.2.7. Russia and CIS Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
8.2.7.1. Russia and CIS Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
8.2.7.2. Russia and CIS Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)
8.2.8. Rest of Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
8.2.8.1. Rest of Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
8.2.8.2. Rest of Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

Chapter 9. Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Countries, 2017 - 2028 (USD Million)
9.1. Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
9.1.1. Market Therapeutic Area and projections, 2017 - 2028 (USD Million)
9.1.2. Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
9.1.3. Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)
9.2. Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Countries, 2017 - 2028 (USD Million)
9.2.1. India Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
9.2.1.1. India Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
9.2.1.2. India Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)
9.2.2. China Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
9.2.2.1. China Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
9.2.2.2. China Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)
9.2.3. Japan Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
9.2.3.1. Japan Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
9.2.3.2. Japan Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)
9.2.4. ASEAN Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
9.2.4.1. ASEAN Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
9.2.4.2. ASEAN Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)
9.2.5. South Korea Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
9.2.5.1. South Korea Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
9.2.5.2. South Korea Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)
9.2.6. Australia Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
9.2.6.1. Australia Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
9.2.6.2. Australia Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)
9.2.7. Rest of Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
9.2.7.1. Rest of Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
9.2.7.2. Rest of Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

Chapter 10. South America Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Countries, 2017 - 2028 (USD Million)
10.1. South America Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
10.1.1. Market Therapeutic Area and projections, 2017 - 2028 (USD Million)
10.1.2. South America Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
10.1.3. South America Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)
10.2. South America Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Countries, 2017 - 2028 (USD Million)
10.2.1. Brazil Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
10.2.1.1. Brazil Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
10.2.1.2. Brazil Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)
10.2.2. Argentina Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
10.2.2.1. Argentina Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
10.2.2.2. Argentina Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)
10.2.3. Rest of South America Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
10.2.3.1. Rest of South America Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
10.2.3.2. Rest of South America Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

Chapter 11. Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Countries, 2017 - 2028 (USD Million)
11.1. Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
11.1.1. Market Therapeutic Area and projections, 2017 - 2028 (USD Million)
11.1.2. Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
11.1.3. Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)
11.2. Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Countries, 2017 - 2028 (USD Million)
11.2.1. GCC Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
11.2.1.1. GCC Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
11.2.1.2. GCC Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)
11.2.2. South Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
11.2.2.1. South Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
11.2.2.2. South Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)
11.2.3. Rest of Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2017 - 2028 (USD Million)
11.2.3.1. Rest of Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Service, 2017 - 2028 (USD Million)
11.2.3.2. Rest of Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, By Therapeutic Area, 2017 - 2028 (USD Million)

Chapter 12. Competitive Landscape
12.1. Competitive Environment, 2021
12.2. Strategic Framework
12.2.1. Partnership/Collaborations/Agreement
12.2.2. Expansion
12.2.3. Mergers & Acquisitions
12.2.4. New Product Development

Chapter 13. Key Vendor Analysis
13.1. Ashfield (UDG Healthcare plc)
13.1.1. Business Overview
13.1.2. Product Benchmarking
13.1.3. Financial Data
13.1.4. Strategic Overview
13.1.5. Key Developments
13.1.6. SWOT Analysis
13.2. inVentiv Health, Inc. (Syneos Health)
13.2.1. Business Overview
13.2.2. Product Benchmarking
13.2.3. Financial Data
13.2.4. Strategic Overview
13.2.5. Key Developments
13.2.6. SWOT Analysis
13.3. IQVIA
13.3.1. Business Overview
13.3.2. Product Benchmarking
13.3.3. Financial Data
13.3.4. Strategic Overview
13.3.5. Key Developments
13.3.6. SWOT Analysis
13.4. Granard Pharmaceutical Sales & Marketing
13.4.1. Business Overview
13.4.2. Product Benchmarking
13.4.3. Financial Data
13.4.4. Strategic Overview
13.4.5. Key Developments
13.4.6. SWOT Analysis
13.5. Vanguard Pharma, Inc.
13.5.1. Business Overview
13.5.2. Product Benchmarking
13.5.3. Financial Data
13.5.4. Strategic Overview
13.5.5. Key Developments
13.5.6. SWOT Analysis
13.6. GTS Solution
13.6.1. Business Overview
13.6.2. Product Benchmarking
13.6.3. Financial Data
13.6.4. Strategic Overview
13.6.5. Key Developments
13.6.6. SWOT Analysis
13.7. EVERSANA
13.7.1. Business Overview
13.7.2. Product Benchmarking
13.7.3. Financial Data
13.7.4. Strategic Overview
13.7.5. Key Developments
13.7.6. SWOT Analysis
13.8. MaBiCo
13.8.1. Business Overview
13.8.2. Product Benchmarking
13.8.3. Financial Data
13.8.4. Strategic Overview
13.8.5. Key Developments
13.8.6. SWOT Analysis
13.9. QFR Solutions
13.9.1. Business Overview
13.9.2. Product Benchmarking
13.9.3. Financial Data
13.9.4. Strategic Overview
13.9.5. Key Developments
13.9.6. SWOT Analysis
13.10. Pharmaforce Ireland Ltd.
13.10.1. Business Overview
13.10.2. Product Benchmarking
13.10.3. Financial Data
13.10.4. Strategic Overview
13.10.5. Key Developments
13.10.6. SWOT Analysis
13.11. Sales Focus, Inc.
13.11.1. Business Overview
13.11.2. Product Benchmarking
13.11.3. Financial Data
13.11.4. Strategic Overview
13.11.5. Key Developments
13.11.6. SWOT Analysis
13.12. Amplity Health
13.12.1. Business Overview
13.12.2. Product Benchmarking
13.12.3. Financial Data
13.12.4. Strategic Overview
13.12.5. Key Developments
13.12.6. SWOT Analysis
13.13. PharmaLex GmbH
13.13.1. Business Overview
13.13.2. Product Benchmarking
13.13.3. Financial Data
13.13.4. Strategic Overview
13.13.5. Key Developments
13.13.6. SWOT Analysis

Chapter 14. Future Outlook of the Market
Disclaimer